The FDA has introduced Elsa, a generative AI tool, to enhance the efficiency of its employees. Elsa, a large language model, operates within a high-security government cloud environment, ensuring that all data remains internal. The tool does not train on data from regulated industries, safeguarding sensitive information. Currently, Elsa is used to expedite clinical protocol reviews, reduce scientific evaluation times, and identify high-priority inspection targets. It can summarize adverse events, perform quicker label comparisons, and generate code for nonclinical database development. Following a successful pilot, the FDA aims to scale AI agency-wide by June 30. The rollout of Elsa is ahead of schedule and under budget, thanks to in-house collaboration. As employees use the tool, the development team will adapt and expand its capabilities to meet evolving needs.
U.S. FDA
@US_FDA
·
May 8 In a historic first for the agency,
@DrMakaryFDA
today announced an aggressive timeline to scale use of artificial intelligence (AI) internally across all FDA centers by June 30, 2025, following the completion of a new generative AI pilot for scientific reviewers.
U.S. FDA
@US_FDA
·
Jun 2 Today, the FDA launched Elsa, a generative AI tool designed to help employees—from scientific reviewers to investigators—work more efficiently. This innovative tool modernizes agency functions and leverages AI capabilities to better serve the American people.
Elsa in Action
➤
Talking Medicines
@TMedicines
·
Jun 2 Pharma agencies don’t need more data—they need the right expertise to act on it.
70–80% faster analysis
Enhance HCP engagement
20–30% boost in predictive accuracy
Built for FDA/EMA compliance
Why AI Experts are now essential:
https://hubs.la/Q03q5K2c0
Rapid Response 47
@RapidResponse47
·
May 9 FDA Commissioner
@MartyMakary
announces the first scientific product review done with AI: “What normally took days to do was done by the AI in 6 minutes…I’ve set an aggressive target to get this AI tool used agency-wide by July 1st…I see incredible things in the pipeline.”
Eric Daugherty
@EricLDaugh
·
May 9 BREAKING: Trump’s FDA is now implementing artificial intelligence for scientific product reviews… the impact? What took several days was done by AI in just 6 MINUTES.
THIS is a huge part of government efficiency.
FDA COMMISSIONER MAKARY: “The president has told us to do
HustleBitch
@HustleBitch_
·
Jun 4 FDA GIVES AI CONTROL OVER DRUG APPROVALS
This is terrifying news. They just quietly handed AI the keys to your medicine cabinet.
The U.S. Food and Drug Administration just unveiled something called “Elsa”, an artificial intelligence system that now reviews scientific and
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
